Alembic City, a flagship integrated development by Alembic Real Estate in Bengaluru's Whitefield, has reached a significant milestone. A renowned global technology company has leased 2.4 million sq.
┌──────────────────────────────────────────────────────� ...
Fintel reports that on January 15, 2026, Alembic Global initiated coverage of ATI (NYSE:ATI) with a Overweight recommendation. Analyst Price Forecast Suggests 1.04% Downside As of January 14, 2026, ...
Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...
In a pivotal move for investors, Peter Skibitski of Alembic Global raised his rating on Northrop Grumman Corporation (NOC) to “Overweight” on December 15, 2025. This assessment signals strong ...
International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...
Alembic Technologies, a pioneer in Causal AI for the enterprise, today announced it has secured $145 million in Series B and growth funding - a 15.7x increase in valuation over their Series A round.
Alembic Technologies raises $145M and buys an Nvidia-powered supercomputer to accelerate ‘causal AI’
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...
Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...
Oct 31 (Reuters) - Indian drugmaker Alembic Pharmaceuticals (ALEM.NS), opens new tab posted a 20.4% rise in second-quarter profit on Tuesday, aided by strong demand for its generic drugs as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results